mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.1 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.1 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |